Henatinib is an orally active small molecule multi-kinase inhibitor with broad antitumour effects. henatinib inhibits the activity of VEGFR-2 (IC50: 0.6 nM), c-kit (IC50: 3.3 nM), PDGFR (IC50: 41.5 nM). henatinib significantly inhibits VEGFR-2 phosphorylation and its downstream signalling pathways in human umbilical vein endothelial cells (HUVECs). Henatinib significantly inhibited VEGFR-2 phosphorylation and its downstream signaling pathway in human umbilical vein endothelial cells (HUVECs).
Molecular Weight:
468.52
CAS Number:
[1239269-51-2]
Formula:
C25H29FN4O4
Target:
VEGFR|||Others|||PDGFR|||c-Kit
T63011
* VAT and and shipping costs not included. Errors and price changes excepted
